Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 11/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | AHR | P35869 | 1/20 | 0.57 |
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CTSV | O60911 | 1/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278605 | 0.90 | KIF11 (0.81) | KIF11ALDH1A1KDM4EAHR | |
| SCHEMBL29864765 | 0.90 | KIF11 (0.81) | KIF11ALDH1A1KDM4EAHR | |
| SCHEMBL4812375 | 0.89 | KIF11 (0.79) | KIF11ALDH1A1KDM4EAHRGPR3 | |
| SCHEMBL12181003 | 0.88 | KIF11 (0.78) | KIF11ALDH1A1KDM4EAHRGPR3 | |
| SCHEMBL6009616 | 0.85 | KIF11 (0.74) | KIF11ALDH1A1KDM4EAHRGPR3 | |
| SCHEMBL28521664 | 0.82 | KIF11 (0.70) | KIF11ALDH1A1KDM4EAHRGPR3 | |
| SCHEMBL11296266 | 0.81 | KIF11 (0.68) | KIF11ALDH1A1KDM4EAHRGPR3 | |
| SCHEMBL1998633 | 0.81 | KIF11 (0.68) | KIF11ALDH1A1KDM4EAHRGPR3 | |
| SCHEMBL6009663 | 0.81 | KIF11 (0.68) | KIF11ALDH1A1KDM4EHSD17B10MAPT | |
| SCHEMBL28165978 | 0.81 | KIF11 (0.68) | KIF11ALDH1A1KDM4EAHRGPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11832515-B2 | Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. | 2023-11-28 | — | — | US | disclosed |
| CN-116635442-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2023-08-22 | — | — | CN | disclosed |
| CN-111013662-B | Organic hydrogen storage liquid hydrogenation or dehydrogenation catalyst with enhanced performance of metal hydride and preparation method thereof | 苏州清德氢能源科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| EP-3452464-B1 | PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF | HOFFMANN LA ROCHE (CH) | 2021-12-15 | — | — | EP | disclosed |
| EP-3760611-A1 | COMPOUND, RESIN, COMPOSITION AND FILM-FORMING MATERIAL FOR LITHOGRAPHY USING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-01-06 | — | — | EP | disclosed |
| CN-111013662-A | Organic hydrogen storage liquid hydrogenation or dehydrogenation catalyst with enhanced performance of metal hydride and preparation method thereof | 苏州明德新能源技术有限公司 | 2020-04-17 | — | — | CN | disclosed |
| US-10043978-B2 | Organic semiconductor formulations | FLEXTERRA, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| US-10032996-B2 | Hetero-cyclic compound and organic light emitting device including the same | LG CHEM, LTD. (KR) | 2018-07-24 | — | — | US | disclosed |
| WO-2017191098-A1 | PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2017-11-09 | — | — | WO | disclosed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | disclosed |
| US-8134143-B2 | 2,7-carbazolenevinylene derivatives as novel materials in producing organic based electronic devices | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2012-03-13 | — | — | US | disclosed |
| US-7939666-B2 | Enzyme inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-05-10 | — | — | US | disclosed |
| US-7932246-B2 | Histone deacetylase inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-04-26 | — | — | US | disclosed |
| US-20090291978-A1 | Enzyme Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2009-11-26 | — | — | US | disclosed |
| US-20070176163-A1 | 2,7-Carbazolenevinylene derivatives as novel materials in producing organic based electronic devices | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2007-08-02 | — | — | US | disclosed |
| US-20060183022-A1 | Electrochemical cell | NEC TOKIN CORORATION (JP) | 2006-08-17 | — | — | US | disclosed |
| US-20060124017-A1 | New compounds, a process for their preparation and their use as dyes and pigments | CIBA SPECIALTY CHEMICALS CORP. | 2006-06-15 | — | — | US | disclosed |
| CN-1761650-A | Compounds, a process for their preparation and their use as dyes and pigments | CIBA SC HOLDING AG (CH) | 2006-04-19 | — | — | CN | disclosed |
| US-5028603-A | Platelet-Activating Factor Antagonist; Useful In Treatment Of Inflammatory Diseases, Allergic Diseases, Asthma, Respiratory System Disorders | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1991-07-02 | — | — | US | disclosed |
| EP-0316456-A1 | ESTER-SUBSTITUTED THIENOTRIAZOLODIAZEPINE COMPOUNDS AND THEIR MEDICINAL USE | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1989-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10032996-B2 | Hetero-cyclic compound and organic light emitting device including the same | CRY1, CRY2, PER2 | KIF11 3681/4885ALDH1A1 1489/4885KDM4E 2560/4885 |
| US-11832515-B2 | Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device | OR10J3, ELAVL1, ICOSLG | KIF11 1363/4885ALDH1A1 973/4885KDM4E 806/4885 |
| US-20090291978-A1 | Enzyme Inhibitors | HAT1, NR2E1, NR2C2 | KIF11 4724/4885ALDH1A1 1343/4885KDM4E 872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.